Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TOPROL-XL
- African American Study of Kidney Disease and Hypertension
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
- Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
- Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
- Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
- Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
- Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition
- Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions
- Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
- Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
- Nebivolol Versus Metoprolol: Sodium Sensitivity
- Coreg CR, Blood Vessel Stiffness and Blood Vessel Function
- Using Beta Blockers to Treat Mitral Regurgitation
- Factorial Study of Metoprolol Succinate TOPROL-XL (324A)
- Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
- BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
- COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
- 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects
- Reducing Total Cardiovascular Risk in an Urban Community
- COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
- Reversal of Ventricular Remodeling With Toprol-XL
Clinical trials list
click for details